Skip to nav Skip to content

IDSA Media Briefing: COVID-19 Therapies Lessons Learned

Facebook Twitter LinkedIn Email

A media briefing from experts from the Infectious Diseases Society of America to discuss COVID-19 treatment.

  • How clinical trials can be improved
  • Standards needed for the FDA’s Emergency Use Authorizations
  • Molnupiravir review process
  • Infrastructure needed to respond to for future pandemics


Adarsh Bhimraj, MD, FIDSA—Cleveland, OH
Fellow—Infectious Diseases Society of America
Chair—IDSA COVID-19 Treatment and Management Guidelines Expert Panel
Head of the Neurologic Infectious Diseases Section, Department of Infectious Diseases, Cleveland Clinic
Associate Staff Physician, Department of Infectious Diseases, Cleveland Clinic

Rajesh T. Gandhi, MD, FIDSA—Boston, MA
Fellow—Infectious Diseases Society of America
Immediate Past President—HIV Medicine Association
Professor of Medicine, Harvard Medical School
Director of HIV Clinical Services and Education, Massachusetts General Hospital

Chris Busky, CAE (Moderator)
Chief Executive Officer—Infectious Diseases Society of America

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.